Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 10 Startups & Unicorns companies in Imipenem
by Most News Heat in the world in 2019

The Imipenem top 10 is Discovery PatSnap’ annual ranking of the top 10 Most News Heat Imipenem Startups & Unicorns in the world. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2019, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Imipenem (Primaxin among others) is an intravenous β-lactam antibiotic discovered by Merck scientists Burton Christensen, William Leanza, and Kenneth Wildonger in the mid-1970s. Carbapenems are highly resistant to the β-lactamase enzymes produced by many multiple drug-resistant Gram-negative bacteria, thus play a key role in the treatment of infections not readily treated with other antibiotics.
#
Company Name
Region
Tech Topics
Total
1
Medicine,Health care,Enterobacteriaceae Infections,
...[+2]
news: 4
2
news: 1
3
Gene,Medicine,Health care,
...[+2]
news: 1
4
Health care,Pharmacy and Therapeutics,Conjugate,
...[+2]
news: 1
5
NHS Warrington Clinical Commissioning Group
United Kingdom
news: 1
6
Keymetrics, Inc.
news: 1
7
news: 1
8
Master Share Price
Technical analysis
news: 1
9
Pharmacy and Therapeutics,Blinatumomab,Antibody,
...[+2]
news: 1
10
news: 1
Page generation time: Apr 28 2025